RENE — ReNeuron Balance Sheet
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- £1.93m
- -£2.80m
- £0.53m
Annual balance sheet for ReNeuron, fiscal year end - March 31st, GBP millions except per share, conversion factor applied.
R2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Interim Report | ARS | ARS | ARS | ARS |
| Standards: | — | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 26.4 | 12.6 | 22.2 | 14.5 | 7.15 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 3.6 | 6.12 | 2.05 | 1.56 | 1.41 |
| Prepaid Expenses | |||||
| Total Current Assets | 30 | 19.1 | 24.5 | 16.5 | 8.84 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 1.34 | 1.04 | 0.686 | 0.661 | 0.621 |
| Net Intangible Assets | |||||
| Total Assets | 31.5 | 20.4 | 25.4 | 17.3 | 9.64 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Current Liabilities | 7.4 | 6.45 | 5.88 | 7.02 | 4.32 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 8.27 | 7.15 | 6.45 | 7.43 | 4.59 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 23.2 | 13.2 | 18.9 | 9.89 | 5.06 |
| Total Liabilities & Shareholders' Equity | 31.5 | 20.4 | 25.4 | 17.3 | 9.64 |
| Total Common Shares Outstanding |